Search for:

Support Us
News and Press Releases
Events
Careers
ShareEx Login

About ICCR
Our Work
Resources
Resolutions
Membership
Current Initiatives
Donate

Back About ICCR

About ICCR

Who We Are
How We Work

Back Our Work

Our Work

Advancing Worker Justice
Corporate Political Responsibility
- Corporate Lobbying
- Corporate Political Spending
Climate Change and Environmental Justice
Equitable Global Supply Chains
Health Equity
Digital Rights and AI Accountability
Investor Responsibility

Back Resources

Resources

Back Resolutions

Resolutions

Back Membership

Membership

Member Directory
Member Benefits
Become a Member
ICCR's Legacy Award

Back Current Initiatives

Current Initiatives

Back Donate

Donate

Home » In The News » Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right

Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right

Julie Wokaty / 21 April 2022

Stat News

Julie Wokaty

Always stay up-to-date.

Join Our Mailing List

Subscribe to ICCR's eNewsletter "The Corporate Examiner".

Name

First

Email

CAPTCHA

Interfaith Center on Corporate Responsibility

475 Riverside Drive
New York, NY 10027 USA

info@ICCR.org 212-870-2295

Press Inquiries
Our Annual Report and Financial Statement
Contact Us

donate Become a member

Follow Us

Copyright 2023 EIN: EIN: 12-3456789 ICCR Nonprofit Marketing Agency by Elevation Web

Terms of Use Privacy Policy Sitemap